Non Regulatory April 1, 2025 Vivesto reports positive Cantrixil results in an animal hematological cancer model
Regulatory March 31, 2025 Vivesto signs deal with Kazia Therapeutics to acquire full Cantrixil rights
Non Regulatory January 16, 2025 Vivesto receives approval to initiate a dose-finding study of Paccal Vet in cats
